Trilogy Capital’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History
Bought
Maintained
Sold
Other funds holding AVEM
AAS
ORL
GI
AC
AP
FWP
RWM
FFA
WA
BHWM
Trilogy Capital's AVEM Position: Q2 2026 in Review
Trilogy Capital reduced its Avantis Emerging Markets Equity ETF (AVEM) stake by 3.3% in Q2 2026, selling an estimated $85.8K and leaving 27,328 shares worth $2.64M. The position accounts for 0.1% of the portfolio, ranked #145.
Trilogy Capital first reported a position in AVEM in Q3 2022 and has held it in 16 quarters since. The position peaked at $15.9M in Q3 2024. 192 funds tracked by Wall St. Rank hold AVEM as of Q2 2026.
- Trilogy Capital held 27,328 shares of Avantis Emerging Markets Equity ETF worth $2.64M as of Q2 2026.
- Trilogy Capital sold 930 Avantis Emerging Markets Equity ETF shares in Q2 2026, an estimated $85.8K.
- Avantis Emerging Markets Equity ETF made up 0.1% of Trilogy Capital's portfolio in Q2 2026, its #145 holding.
- Trilogy Capital first reported a position in Avantis Emerging Markets Equity ETF in Q3 2022 and has held it in 16 quarters since.
- Trilogy Capital's Avantis Emerging Markets Equity ETF position peaked at $15.9M in Q3 2024.
- 192 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q2 2026.
Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.